FCADX | RERAX | FCADX / RERAX | |
Total Expense Ratio | 1.62 | 1.57 | 103% |
Annual Report Gross Expense Ratio | 1.62 | 1.57 | 103% |
Fund Existence | 21 years | 23 years | - |
Gain YTD | 17.017 | 11.481 | 148% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.3B | 133B | 8% |
Annual Yield % from dividends | 1.55 | 0.23 | 663% |
Returns for 1 year | 9.73 | 0.88 | 1,112% |
Returns for 3 years | 49.46 | 27.31 | 181% |
Returns for 5 years | 25.12 | 8.79 | 286% |
Returns for 10 years | 36.49 | 16.66 | 219% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
KDEF | 41.14 | 1.16 | +2.90% |
Plus Korea Defense Industry Index ETF | |||
DGIN | 43.55 | 0.36 | +0.84% |
VanEck Digital India ETF | |||
IWMY | 23.97 | 0.20 | +0.84% |
Defiance R2000 Target 30 Income ETF | |||
HQL | 13.05 | 0.09 | +0.69% |
abrdn Life Sciences Investors | |||
GRID | 139.46 | 0.63 | +0.45% |
First Trust NASDAQ® Cln Edge®StGidIfsETF |